Pcn332 - Real-World Usage of Bortezomib in Combination With Thalidomide and Dexamethasone (Vtd) as Frontline (Fl) Treatment in Stem Cell Transplant (Sct) Eligible Multiple Myeloma (Mm) Patients Across Eu5 Countries

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.414

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Pcn340 - Real-World Usage of Bortezomib in Combination With Melphalan and Prednisone (Vmp) as Frontline (Fl) Treatment in Stem Cell Transplant (Sct) Ineligible Multiple Myeloma (Mm) Patients Across Eu5 Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Bortezomib-Based Regimens Used as Induction in Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible for Stem Cell Transplantation (Sct)The Cost-Utility Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Maintenance Therapy With Low Dose Thalidomide, Dexamethasone and Clarithromycin (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2011English

STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models

Oncotarget
Oncology
2018English

Effect of Thalidomide on Stem Cell Collection and Engraftment in Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2003English

Phase II Trial to Investigate Efficacy and Safety of Bendamustine, Dexamethasone and Thalidomide in Relapsed or Refractory Multiple Myeloma Patients After Treatment With Lenalidomide and Bortezomib

British Journal of Haematology
Hematology
2018English

Neurotoxicity of Stem Cell Mobilization Chemotherapy With Vinorelbine in Myeloma Patients After Bortezomib Treatment

Leukemia Research
Cancer ResearchOncologyHematology
2015English

Low-Dose Lenalidomide and Dexamethasone Combination Treatment in Elderly Patients With Relapsed and Refractory Multiple Myeloma

Hematology
Hematology
2016English

Bortezomib Plus Dexamethasone Induction Followed by Autologous Stem Cell Transplantation in Multiple Myeloma: A Study From India

Asian Journal of Medical Sciences
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy